Incyte - 31 Year Stock Price History | INCY

Historical daily share price chart and data for Incyte since 1993 adjusted for splits and dividends. The latest closing stock price for Incyte as of April 22, 2024 is 51.92.
  • The all-time high Incyte stock closing price was 152.66 on March 15, 2017.
  • The Incyte 52-week high stock price is 75.74, which is 45.9% above the current share price.
  • The Incyte 52-week low stock price is 50.27, which is 3.2% below the current share price.
  • The average Incyte stock price for the last 52 weeks is 60.33.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Incyte Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 58.8326 65.4500 66.5900 51.9200 51.9200 -17.31%
2023 66.1166 79.5500 86.0100 52.1600 62.7900 -21.83%
2022 74.7658 73.9700 84.1100 66.0200 80.3200 9.43%
2021 77.9284 86.4500 100.5000 63.3400 73.4000 -15.61%
2020 88.8053 85.9700 109.6900 63.1800 86.9800 -0.39%
2019 81.9818 63.5600 95.7200 63.5600 87.3200 37.32%
2018 72.8748 100.8900 100.9800 58.5000 63.5900 -32.86%
2017 121.3776 102.3200 152.6600 93.5600 94.7100 -5.55%
2016 83.5442 103.3200 108.1000 63.0500 100.2700 -7.54%
2015 102.6879 73.7600 131.4700 71.4900 108.4500 48.34%
2014 57.1143 51.2300 78.8900 43.1000 73.1100 44.40%
2013 28.9761 17.0000 51.3400 17.0000 50.6300 204.82%
2012 19.2983 14.9900 25.8400 14.7800 16.6100 10.66%
2011 15.7089 16.5200 20.7600 11.7800 15.0100 -9.36%
2010 13.4671 9.5000 17.1700 9.4100 16.5600 81.78%
2009 4.7656 3.8500 9.4000 2.0500 9.1100 140.37%
2008 8.3997 9.9800 12.4200 2.4900 3.7900 -62.29%
2007 7.1488 6.0200 10.7800 4.8100 10.0500 72.09%
2006 4.8336 5.3400 6.2000 3.5800 5.8400 9.36%
2005 7.1163 9.6400 9.6600 4.2700 5.3400 -46.55%
2004 8.3024 6.8200 10.9600 5.4500 9.9900 46.05%
2003 4.6660 4.9090 6.9100 2.6700 6.8400 50.00%
2002 8.0137 19.4000 19.6900 2.9800 4.5600 -76.54%
2001 18.1810 22.5600 30.6300 10.7600 19.4400 -21.86%
2000 47.9850 44.8150 140.2500 23.5600 24.8800 -17.07%
1999 12.9288 18.5000 31.5650 8.2800 30.0000 60.51%
1998 17.8036 21.3750 25.1900 9.2500 18.6900 -16.93%
1997 16.6527 12.7500 22.5000 10.6250 22.5000 74.76%
1996 9.2842 7.0300 12.8750 6.1250 12.8750 106.00%
1995 4.4132 3.4075 6.2500 3.2825 6.2500 80.12%
1994 2.4212 2.1875 3.9075 1.7188 3.4700 54.22%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $11.754B $3.696B
Incyte Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. The company conducts its European clinical development operations in Geneva, Switzerland. Incyte's lead drug, Jakafi (ruxolitinib), is a first-in-class JAK1/JAK2 inhibitor, approved in the United States for the treatment of patients with polycythemia vera ('PV'),who have had an inadequate response to or are intolerant to hydroxyurea. It is also approved for the treatment of patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-PV MF, and post-essential thrombocythemia MF. The drug is also approved in the United States for treatment of steroid-refractory acute graft-versus-host disease (GVHD) in adult and pediatric patients aged 12 years or older.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $144.247B 14.42
Vertex Pharmaceuticals (VRTX) United States $101.905B 29.34
Bristol Myers Squibb (BMY) United States $99.169B 6.52
Regeneron Pharmaceuticals (REGN) United States $98.437B 23.86
CSL (CSLLY) Australia $83.914B 0.00
Gilead Sciences (GILD) United States $83.121B 9.93
GSK (GSK) United Kingdom $82.379B 10.32
Moderna (MRNA) United States $38.828B 0.00
Biogen (BIIB) United States $28.255B 13.20
Argenex SE (ARGX) Netherlands $21.409B 0.00
BioNTech SE (BNTX) Germany $20.637B 21.07
Genmab (GMAB) Denmark $18.977B 24.32
Illumina (ILMN) United States $18.701B 134.98
Alnylam Pharmaceuticals (ALNY) United States $18.188B 0.00
BioMarin Pharmaceutical (BMRN) United States $16.727B 70.90
BeiGene (BGNE) Cayman Islands $12.387B 0.00
Exact Sciences (EXAS) United States $11.066B 0.00
Sarepta Therapeutics (SRPT) United States $10.857B 0.00
Bio-Techne Corp (TECH) United States $9.765B 36.33
QIAGEN (QGEN) Netherlands $9.128B 18.90
Repligen (RGEN) United States $8.774B 90.83
Roivant Sciences (ROIV) United Kingdom $8.429B 0.00
Legend Biotech (LEGN) United States $8.402B 0.00
Ascendis Pharma (ASND) Denmark $8.161B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.983B 23.78
Cytokinetics (CYTK) United States $7.064B 0.00
Intra-Cellular Therapies (ITCI) United States $7.006B 0.00
Viking Therapeutics (VKTX) United States $6.990B 0.00
Exelixis (EXEL) United States $6.639B 35.19
Vaxcyte (PCVX) United States $6.616B 0.00
Apellis Pharmaceuticals (APLS) United States $5.731B 0.00
Blueprint Medicines (BPMC) United States $5.315B 0.00
Halozyme Therapeutics (HALO) United States $4.909B 15.15
CRISPR Therapeutics AG (CRSP) Switzerland $4.673B 0.00
Krystal Biotech (KRYS) United States $4.520B 0.00
Zealand Pharma (ZLDPF) Denmark $4.331B 0.00
Immunovant (IMVT) United States $4.100B 0.00
Alkermes (ALKS) Ireland $4.035B 21.30
Nuvalent (NUVL) United States $4.021B 0.00
Insmed (INSM) United States $3.613B 0.00
ImmunityBio (IBRX) United States $3.568B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.487B 0.00
Axsome Therapeutics (AXSM) United States $3.217B 0.00
Biohaven (BHVN) United States $3.190B 0.00
Fortrea Holdings (FTRE) United States $3.173B 0.00
Iovance Biotherapeutics (IOVA) United States $3.159B 0.00
Amicus Therapeutics (FOLD) United States $3.134B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.008B 0.00
SpringWorks Therapeutics (SWTX) United States $2.959B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.875B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.774B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.771B 0.00
IDEAYA Biosciences (IDYA) United States $2.768B 0.00
Arcellx (ACLX) United States $2.752B 0.00
Apogee Therapeutics (APGE) United States $2.742B 0.00
MorphoSys AG (MOR) Germany $2.708B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.695B 0.00
Certara (CERT) United States $2.552B 54.93
Janux Therapeutics (JANX) United States $2.515B 0.00
Arvinas (ARVN) United States $2.372B 0.00
CG Oncology (CGON) United States $2.355B 0.00
Merus (MRUS) Netherlands $2.336B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.286B 0.00
Denali Therapeutics (DNLI) United States $2.281B 0.00
Celldex Therapeutics (CLDX) United States $2.123B 0.00
Vericel (VCEL) United States $2.116B 0.00
Keros Therapeutics (KROS) United States $2.102B 0.00
Intellia Therapeutics (NTLA) United States $2.080B 0.00
Kymera Therapeutics (KYMR) United States $2.076B 0.00
Vera Therapeutics (VERA) United States $2.069B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.064B 0.00
Geron (GERN) United States $2.018B 0.00
Guardant Health (GH) United States $1.956B 0.00
Beam Therapeutics (BEAM) United States $1.952B 0.00
Galapagos (GLPG) Belgium $1.916B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.862B 0.00
Avidity Biosciences (RNA) United States $1.812B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.767B 0.00
NeoGenomics (NEO) United States $1.727B 0.00
Structure Therapeutics (GPCR) United States $1.694B 0.00
Sana Biotechnology (SANA) United States $1.678B 0.00
Myriad Genetics (MYGN) United States $1.674B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.670B 13.87
Bavarian Nordic (BVNRY) Denmark $1.630B 5.35
Inhibrx (INBX) United States $1.627B 0.00
Neumora Therapeutics (NMRA) United States $1.617B 0.00
Twist Bioscience (TWST) United States $1.616B 0.00
Dynavax Technologies (DVAX) United States $1.544B 0.00
Protagonist Therapeutics (PTGX) United States $1.492B 0.00
Akero Therapeutics (AKRO) United States $1.436B 0.00
ADMA Biologics Inc (ADMA) United States $1.431B 0.00
Edgewise Therapeutics (EWTX) United States $1.418B 0.00
Morphic Holding (MORF) United States $1.401B 0.00
Zai Lab (ZLAB) China $1.396B 0.00
ANI Pharmaceuticals (ANIP) United States $1.380B 16.96
Kura Oncology (KURA) United States $1.335B 0.00
Arcus Biosciences (RCUS) United States $1.326B 0.00
Gyre Therapeutics (GYRE) United States $1.325B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.307B 0.00
Ligand Pharmaceuticals (LGND) United States $1.283B 15.89
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.270B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.202B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.194B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.185B 0.00
Spyre Therapeutics (SYRE) United States $1.172B 0.00
Prothena (PRTA) Ireland $1.137B 0.00
AbCellera Biologics (ABCL) Canada $1.133B 0.00
MannKind (MNKD) United States $1.131B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.119B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.110B 0.00
Scholar Rock Holding (SRRK) United States $1.078B 0.00
Vir Biotechnology (VIR) United States $1.069B 0.00
Liquidia Technologies (LQDA) United States $1.010B 0.00
Belite Bio (BLTE) United States $0.974B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.971B 0.00
Abivax SA (ABVX) France $0.963B 0.00
MiMedx (MDXG) United States $0.924B 209.67
Immunome (IMNM) United States $0.924B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.920B 0.00
Viridian Therapeutics (VRDN) United States $0.916B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.881B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.880B 0.00
89BIO (ETNB) United States $0.865B 0.00
Immatics (IMTX) Germany $0.864B 0.00
Tyra Biosciences (TYRA) United States $0.787B 0.00
Kyverna Therapeutics (KYTX) United States $0.785B 0.00
Tango Therapeutics (TNGX) United States $0.780B 0.00
ALX Oncology Holdings (ALXO) United States $0.780B 0.00
Cytek Biosciences (CTKB) United States $0.774B 0.00
REGENXBIO (RGNX) United States $0.769B 0.00
CARGO Therapeutics (CRGX) United States $0.755B 0.00
Pliant Therapeutics (PLRX) United States $0.754B 0.00
PureTech Health (PRTC) United States $0.706B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.705B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.699B 0.00
Disc Medicine (IRON) United States $0.693B 0.00
Dianthus Therapeutics (DNTH) United States $0.682B 0.00
Cullinan Oncology (CGEM) United States $0.674B 0.00
Pharming Group (PHAR) Netherlands $0.671B 0.00
Nurix Therapeutics (NRIX) United States $0.668B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.662B 0.00
EnGene Holdings (ENGN) United States $0.647B 0.00
Cabaletta Bio (CABA) United States $0.644B 0.00
Cogent Biosciences (COGT) United States $0.642B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.628B 0.00
Zymeworks (ZYME) United States $0.625B 0.00
Praxis Precision Medicines (PRAX) United States $0.621B 0.00
Pharming Group (PHGUF) Netherlands $0.620B 0.00
Oric Pharmaceuticals (ORIC) United States $0.619B 0.00
Aerovate Therapeutics (AVTE) United States $0.614B 0.00
HilleVax (HLVX) United States $0.612B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.610B 0.00
WAVE Life Sciences (WVE) Singapore $0.596B 0.00
Mesoblast (MESO) Australia $0.594B 0.00
Allogene Therapeutics (ALLO) United States $0.587B 0.00
Northwest Biotherapeutics (NWBO) United States $0.578B 0.00
GH Research (GHRS) Ireland $0.574B 0.00
Nuvation Bio (NUVB) United States $0.567B 0.00
Mineralys Therapeutics (MLYS) United States $0.560B 0.00
Stoke Therapeutics (STOK) United States $0.558B 0.00
Novavax (NVAX) United States $0.556B 0.00
Olema Pharmaceuticals (OLMA) United States $0.555B 0.00
CureVac (CVAC) Germany $0.546B 0.00
Fate Therapeutics (FATE) United States $0.545B 0.00
Prime Medicine (PRME) United States $0.541B 0.00
Absci (ABSI) United States $0.538B 0.00
Astria Therapeutics (ATXS) United States $0.535B 0.00
AnaptysBio (ANAB) United States $0.532B 0.00
Castle Biosciences (CSTL) United States $0.530B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
Celcuity (CELC) United States $0.525B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.525B 0.00
ArriVent BioPharma (AVBP) United States $0.519B 0.00
ACELYRIN, INC (SLRN) United States $0.493B 0.00
Arbutus Biopharma (ABUS) United States $0.488B 0.00
Alector (ALEC) United States $0.487B 0.00
Oculis Holding AG (OCS) Switzerland $0.477B 0.00
Third Harmonic Bio (THRD) United States $0.476B 0.00
Applied Therapeutics (APLT) United States $0.464B 0.00
C4 Therapeutics (CCCC) United States $0.461B 0.00
Adlai Nortye (ANL) Cayman Islands $0.458B 0.00
Shattuck Labs (STTK) United States $0.455B 0.00
Editas Medicine (EDIT) United States $0.451B 0.00
Humacyte (HUMA) United States $0.441B 0.00
Travere Therapeutics (TVTX) United States $0.435B 0.00
Fulcrum Therapeutics (FULC) United States $0.424B 0.00
IGM Biosciences (IGMS) United States $0.423B 0.00
MaxCyte (MXCT) United States $0.412B 0.00
Annexon (ANNX) United States $0.411B 0.00
Entrada Therapeutics (TRDA) United States $0.408B 0.00
Voyager Therapeutics (VYGR) United States $0.407B 2.43
Lexicon Pharmaceuticals (LXRX) United States $0.406B 0.00
Avid Bioservices (CDMO) United States $0.404B 0.00
Replimune (REPL) United States $0.396B 0.00
Mersana Therapeutics (MRSN) United States $0.394B 0.00
Revance Therapeutics (RVNC) United States $0.394B 0.00
Neurogene (NGNE) United States $0.392B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.391B 0.00
Biomea Fusion (BMEA) United States $0.389B 0.00
Anika Therapeutics (ANIK) United States $0.384B 0.00
ITeos Therapeutics (ITOS) United States $0.379B 0.00
Nkarta (NKTX) United States $0.360B 0.00
Aura Biosciences (AURA) United States $0.356B 0.00
Rani Therapeutics Holdings (RANI) United States $0.355B 0.00
Amarin (AMRN) Ireland $0.353B 0.00
Alto Neuroscience (ANRO) United States $0.348B 0.00
Adaptive Biotechnologies (ADPT) United States $0.348B 0.00
Caribou Biosciences (CRBU) United States $0.348B 0.00
PepGen (PEPG) United States $0.341B 0.00
Ocugen (OCGN) United States $0.340B 0.00
Tenaya Therapeutics (TNYA) United States $0.339B 0.00
FibroBiologics (FBLG) United States $0.331B 0.00
Precigen (PGEN) United States $0.331B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.330B 0.00
Solid Biosciences (SLDB) United States $0.329B 0.00
MeiraGTx Holdings (MGTX) United States $0.327B 0.00
TScan Therapeutics (TCRX) United States $0.327B 0.00
Jasper Therapeutics (JSPR) United States $0.325B 0.00
Urogen Pharma (URGN) United States $0.322B 0.00
Ventyx Biosciences (VTYX) United States $0.315B 0.00
Atea Pharmaceuticals (AVIR) United States $0.313B 0.00
Renovaro (RENB) United States $0.312B 0.00
Anavex Life Sciences (AVXL) United States $0.310B 0.00
Nautilus Biotechnology (NAUT) United States $0.308B 0.00
XOMA (XOMA) United States $0.296B 0.00
Terns Pharmaceuticals (TERN) United States $0.295B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.294B 102.20
Monte Rosa Therapeutics (GLUE) United States $0.293B 0.00
Kamada (KMDA) Israel $0.290B 21.96
CorMedix Inc (CRMD) United States $0.289B 0.00
Contineum Therapeutics (CTNM) United States $0.282B 0.00
Inozyme Pharma (INZY) United States $0.279B 0.00
ChromaDex (CDXC) United States $0.278B 0.00
Rapt Therapeutics (RAPT) United States $0.277B 0.00
Invivyd (IVVD) United States $0.274B 0.00
Erasca (ERAS) United States $0.271B 0.00
Werewolf Therapeutics (HOWL) United States $0.256B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.252B 0.00
Verastem (VSTM) United States $0.249B 0.00
XBiotech (XBIT) United States $0.245B 0.00
Puma Biotechnology (PBYI) United States $0.242B 10.89
Adverum Biotechnologies (ADVM) United States $0.235B 0.00
Coherus BioSciences (CHRS) United States $0.235B 0.00
AC Immune (ACIU) Switzerland $0.233B 0.00
23andMe Holding (ME) United States $0.233B 0.00
2seventy Bio (TSVT) United States $0.232B 0.00
Ovid Therapeutics (OVID) United States $0.228B 0.00
Sutro Biopharma (STRO) United States $0.227B 0.00
Inovio Pharmaceuticals (INO) United States $0.226B 0.00
UniQure (QURE) Netherlands $0.223B 0.00
G1 Therapeutics (GTHX) United States $0.215B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.214B 0.00
X4 Pharmaceuticals (XFOR) United States $0.212B 0.00
Design Therapeutics (DSGN) United States $0.209B 0.00
Abeona Therapeutics (ABEO) United States $0.207B 0.00
Lifecore Biomedical (LFCR) United States $0.203B 0.00
Compass Therapeutics (CMPX) United States $0.202B 0.00
Skye Bioscience (SKYE) United States $0.199B 0.00
Codexis (CDXS) United States $0.199B 0.00
Prima BioMed (IMMP) Australia $0.198B 0.00
Innate Pharma S.A (IPHA) France $0.197B 0.00
Trevi Therapeutics (TRVI) United States $0.196B 0.00
Poseida Therapeutics (PSTX) United States $0.195B 0.00
Cardiff Oncology (CRDF) United States $0.194B 0.00
Opthea (OPT) Australia $0.193B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.189B 0.00
Akoya Biosciences (AKYA) United States $0.187B 0.00
Elevation Oncology (ELEV) United States $0.185B 0.00
Gossamer Bio (GOSS) United States $0.177B 0.00
Kodiak Sciences (KOD) United States $0.176B 0.00
Alimera Sciences (ALIM) United States $0.175B 0.00
Inventiva S.A (IVA) France $0.175B 0.00
GENFIT S.A (GNFT) France $0.170B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.166B 0.00
Compugen (CGEN) Israel $0.165B 0.00
ScPharmaceuticals (SCPH) United States $0.164B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.162B 0.00
Adicet Bio (ACET) United States $0.160B 0.00
BioStem Technologies (BSEM) $0.157B 0.00
Greenwich LifeSciences (GLSI) United States $0.155B 0.00
INmune Bio (INMB) United States $0.152B 0.00
Candel Therapeutics (CADL) United States $0.152B 0.00
Scilex Holding (SCLX) United States $0.149B 0.00
CervoMed (CRVO) United States $0.148B 0.00
I-Mab (IMAB) China $0.145B 0.00
Zura Bio (ZURA) United States $0.143B 0.00
Cellectis S.A (CLLS) France $0.142B 0.00
Rezolute (RZLT) United States $0.138B 0.00
Omega Therapeutics (OMGA) United States $0.132B 0.00
DBV Technologies S.A (DBVT) France $0.131B 0.00
VistaGen Therapeutics (VTGN) United States $0.129B 0.00
Sagimet Biosciences (SGMT) United States $0.128B 0.00
Syros Pharmaceuticals (SYRS) United States $0.121B 0.00
Nuvectis Pharma (NVCT) United States $0.121B 0.00
Molecular Partners AG (MOLN) Switzerland $0.121B 0.00
TELA Bio (TELA) United States $0.117B 0.00
Coya Therapeutics (COYA) United States $0.117B 0.00
Vor Biopharma (VOR) $0.117B 0.00
Repare Therapeutics (RPTX) Canada $0.117B 0.00
Adagene (ADAG) China $0.116B 0.00
CytomX Therapeutics (CTMX) United States $0.113B 0.00
Bluebird Bio (BLUE) United States $0.112B 0.00
Agenus (AGEN) United States $0.111B 0.00
Genelux (GNLX) United States $0.111B 0.00
Annovis Bio (ANVS) United States $0.111B 0.00
ATyr Pharma (LIFE) United States $0.109B 0.00
Seer (SEER) United States $0.108B 0.00
Emergent Biosolutions (EBS) United States $0.107B 0.00
Oncobiologics (OTLK) United States $0.106B 0.00
Immunic (IMUX) United States $0.106B 0.00
BioHarvest Sciences (CNVCF) Canada $0.105B 0.00
Vigil Neuroscience (VIGL) United States $0.104B 0.00
BioAtla (BCAB) United States $0.101B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.100B 0.00
Clearside Biomedical (CLSD) United States $0.098B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.098B 0.00
IO Biotech (IOBT) Denmark $0.098B 0.00
PDS Biotechnology (PDSB) United States $0.097B 0.00
Cartesian Therapeutics (RNAC) United States $0.097B 0.00
Allakos (ALLK) United States $0.094B 0.00
Sangamo Therapeutics (SGMO) United States $0.092B 0.00
DiaMedica Therapeutics (DMAC) United States $0.091B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.087B 0.00
Galena Biopharma (SLS) United States $0.087B 0.00
Elicio Therapeutics (ELTX) United States $0.086B 0.00
Connect Biopharma Holdings (CNTB) United States $0.085B 0.00
Seres Therapeutics (MCRB) United States $0.085B 0.00
Curis (CRIS) United States $0.084B 0.00
BioXcel Therapeutics (BTAI) United States $0.084B 0.00
Eton Pharmaceuticals (ETON) United States $0.082B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.082B 0.00
Alpha Teknova (TKNO) United States $0.082B 0.00
Athira Pharma (ATHA) United States $0.082B 0.00
Aileron Therapeutics (ALRN) United States $0.080B 0.00
Oncolytics Biotech (ONCY) Canada $0.080B 0.00
InflaRx (IFRX) Germany $0.079B 0.00
Atara Biotherapeutics (ATRA) United States $0.079B 0.00
Affimed (AFMD) Germany $0.078B 0.00
Cue Biopharma (CUE) United States $0.076B 0.00
Spero Therapeutics (SPRO) United States $0.075B 2.80
BeyondSpring (BYSI) United States $0.074B 0.00
AN2 Therapeutics (ANTX) United States $0.074B 0.00
Q32 Bio (QTTB) United States $0.073B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.073B 0.00
HOOKIPA Pharma (HOOK) United States $0.073B 0.00
VTv Therapeutics (VTVT) United States $0.072B 0.00
Gritstone Bio (GRTS) United States $0.072B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.072B 0.00
Cognition Therapeutics (CGTX) United States $0.072B 0.00
Leap Therapeutics (LPTX) United States $0.072B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.071B 0.00
Genenta Science S.p.A (GNTA) Italy $0.071B 0.00
Passage Bio (PASG) United States $0.071B 0.00
Elutia (ELUT) United States $0.071B 0.00
Instil Bio (TIL) United States $0.069B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.069B 0.00
MediciNova (MNOV) United States $0.068B 0.00
Landos Biopharma (LABP) United States $0.068B 0.00
YS Biopharma (YS) China $0.068B 0.00
Precision BioSciences (DTIL) United States $0.067B 0.00
Rallybio (RLYB) United States $0.067B 0.00
Ikena Oncology (IKNA) United States $0.064B 0.00
Cidara Therapeutics (CDTX) United States $0.062B 0.00
Ocean Biomedical (OCEA) United States $0.061B 0.00
Kronos Bio (KRON) United States $0.061B 0.00
Turnstone Biologics (TSBX) United States $0.061B 0.00
Vaxxinity (VAXX) United States $0.060B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.060B 0.00
Celularity (CELU) United States $0.059B 0.00
LENZ Therapeutics (LENZ) United States $0.058B 0.00
HCW Biologics (HCWB) United States $0.058B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
Kezar Life Sciences (KZR) United States $0.058B 0.00
Lantern Pharma (LTRN) United States $0.057B 0.00
Entera Bio (ENTX) Israel $0.057B 0.00
Equillium (EQ) United States $0.057B 0.00
Aligos Therapeutics (ALGS) United States $0.057B 0.00
Enzo Biochem (ENZ) United States $0.056B 0.00
AVROBIO (AVRO) United States $0.054B 0.00
Intensity Therapeutics (INTS) United States $0.053B 0.00
Immuneering (IMRX) United States $0.053B 0.00
Checkpoint Therapeutics (CKPT) United States $0.052B 0.00
ARCA Biopharma (ABIO) United States $0.049B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.046B 0.00
Dyadic (DYAI) United States $0.046B 0.00
Quince Therapeutics (QNCX) United States $0.045B 0.00
Aadi Bioscience (AADI) United States $0.045B 0.00
Clene (CLNN) United States $0.045B 0.00
NextCure (NXTC) United States $0.045B 0.00
Beyond Air (XAIR) United States $0.044B 0.00
CalciMedica (CALC) United States $0.043B 0.00
Bolt Biotherapeutics (BOLT) United States $0.042B 0.00
Apollomics (APLM) United States $0.042B 0.00
Ocuphire Pharma (OCUP) United States $0.041B 0.00
Bionano Genomics (BNGO) United States $0.041B 0.00
OKYO Pharma (OKYO) $0.040B 0.00
Xilio Therapeutics (XLO) United States $0.040B 0.00
SAB Biotherapeutics (SABS) United States $0.040B 0.00
Estrella Immunopharma (ESLA) United States $0.039B 0.00
Carmell (CTCX) United States $0.038B 0.00
Promis Neurosciences (PMN) Canada $0.037B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.036B 0.00
Cara Therapeutics (CARA) United States $0.036B 0.00
Fortress Biotech (FBIO) United States $0.034B 0.00
Cyclo Therapeutics (CYTH) United States $0.033B 0.00
IN8bio (INAB) United States $0.033B 0.00
Theratechnologies (THTX) Canada $0.033B 0.00
BRIACELL THERAP (BCTX) Canada $0.032B 0.00
BioAffinity Technologies (BIAF) United States $0.032B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.032B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Semper Paratus Acquisition (TVGN) United States $0.029B 0.00
Femasys (FEMY) United States $0.029B 0.00
Aprea Therapeutics (APRE) United States $0.029B 0.00
Spruce Biosciences (SPRB) United States $0.029B 0.00
Lexaria Bioscience (LEXX) Canada $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
Pluri (PLUR) Israel $0.027B 0.00
Eyenovia (EYEN) United States $0.027B 0.00
Forte Biosciences (FBRX) United States $0.027B 0.00
Prenetics Global (PRE) Cayman Islands $0.027B 0.00
Evogene (EVGN) Israel $0.025B 0.00
NKGen Biotech (NKGN) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
Sensei Biotherapeutics (SNSE) United States $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
Evaxion Biotech (EVAX) Denmark $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Biora Therapeutics (BIOR) United States $0.022B 0.00
Synlogic (SYBX) United States $0.022B 0.00
Lumos Pharma (LUMO) United States $0.021B 0.00
RenovoRx (RNXT) United States $0.020B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.019B 0.00
Aptose Biosciences (APTO) Canada $0.019B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.019B 0.00
KALA BIO (KALA) United States $0.019B 0.00
Galecto (GLTO) Denmark $0.018B 0.00
Vincerx Pharma (VINC) United States $0.018B 0.00
Benitec Biopharma (BNTC) United States $0.018B 0.00
VBI Vaccines (VBIV) United States $0.018B 0.00
Orgenesis (ORGS) United States $0.017B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Senti Biosciences (SNTI) United States $0.014B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.012B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.012B 0.00
Eterna Therapeutics (ERNA) United States $0.012B 0.00
Purple Biotech (PPBT) Israel $0.011B 0.00
Monopar Therapeutics (MNPR) United States $0.011B 0.00
Organovo Holdings (ONVO) United States $0.011B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.011B 0.00
Imunon (IMNN) United States $0.011B 0.00
ABVC BioPharma (ABVC) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
Galera Therapeutics (GRTX) United States $0.010B 0.00
Elevai Labs (ELAB) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
AEterna Zentaris (AEZS) Canada $0.009B 0.00
Telesis Bio (TBIO) United States $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.009B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Virios Therapeutics (VIRI) United States $0.008B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
TFF Pharmaceuticals (TFFP) United States $0.008B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.008B 0.00
Chemomab Therapeutics (CMMB) Israel $0.008B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Trevena (TRVN) United States $0.006B 0.00
Cadrenal Therapeutics (CVKD) United States $0.006B 0.00
Enveric Biosciences (ENVB) United States $0.006B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
Psyence Biomedical (PBM) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Kineta (KA) United States $0.006B 0.00
Atrinsic (PTIX) United States $0.006B 0.00
PaxMedica (PXMD) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
First Wave BioPharma (FWBI) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.33
Longeveron (LGVN) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
Kintara Therapeutics (KTRA) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Seelos Therapeutics (SEEL) United States $0.005B 0.00
Soligenix (SNGX) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Biophytis SA (BPTS) France $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Invo BioScience (INVO) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
ThermoGenesis Holdings (THMO) United States $0.002B 0.00
Sunshine Biopharma (SBFM) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
GRI Bio (GRI) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.000B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00